Connecting you to content on EBSCOhost

Works by Ruddle, Ruth

Results: 5

1

ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma.

Published in:

Communications Biology, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1038/s42003-019-0420-8

By:

Carvalho, Diana;
Taylor, Kathryn R.;
Olaciregui, Nagore Gene;
Molinari, Valeria;
Clarke, Matthew;
Mackay, Alan;
Ruddle, Ruth;
Henley, Alan;
Valenti, Melanie;
Hayes, Angela;
Brandon, Alexis De Haven;
Eccles, Suzanne A.;
Raynaud, Florence;
Boudhar, Aicha;
Monje, Michelle;
Popov, Sergey;
Moore, Andrew S.;
Mora, Jaume;
Cruz, Ofelia;
Vinci, Mara

Publication type:

Article

2

Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.

Published in:

2018

By:

Banerji, Udai;
Sain, Nivedita;
Sharp, Swee Y.;
Valenti, Melanie;
Asad, Yasmin;
Ruddle, Ruth;
Raynaud, Florence;
Walton, Michael;
Eccles, Suzanne A.;
Judson, Ian;
Jackman, Ann L.;
Workman, Paul

Publication type:

Correction Notice

3

Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.

Published in:

2018

By:

Banerji, Udai;
Sain, Nivedita;
Sharp, Swee Y;
Valenti, Melanie;
Asad, Yasmin;
Ruddle, Ruth;
Raynaud, Florence;
Walton, Michael;
Eccles, Suzanne A;
Judson, Ian;
Jackman, Ann L;
Workman, Paul

Publication type:

corrected article

4

An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 769, doi. 10.1007/s00280-007-0662-x

By:

Banerji, Udai;
Sain, Nivedita;
Sharp, Swee Y.;
Valenti, Melanie;
Asad, Yasmin;
Ruddle, Ruth;
Raynaud, Florence;
Walton, Michael;
Eccles, Suzanne A.;
Judson, Ian;
Jackman, Ann L.;
Workman, Paul

Publication type:

Article

5

Metabolomic changes of the multi (-AGC-) kinase inhibitor AT13148 in cells, mice and patients are associated with NOS regulation.

Published in:

Metabolomics, 2020, v. 16, n. 4, p. 1, doi. 10.1007/s11306-020-01676-0

By:

Pal, Akos;
Asad, Yasmin;
Ruddle, Ruth;
Henley, Alan T.;
Swales, Karen;
Decordova, Shaun;
Eccles, Suzanne A.;
Collins, Ian;
Garrett, Michelle D.;
De Bono, Johann;
Banerji, Udai;
Raynaud, Florence I.

Publication type:

Article